ASO Author Reflections: Tumor Response After the First Course of Neoadjuvant Chemotherapy Reflects Prognosis After Surgery in Patients with Esophageal Squamous Cell Carcinoma

被引:0
|
作者
Hagi, Takaomi [1 ]
Shiraishi, Osamu [1 ]
Yasuda, Takushi [1 ]
机构
[1] Kindai Univ, Fac Med, Dept Surg, Osaka, Japan
关键词
D O I
10.1245/s10434-024-15371-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:5310 / 5311
页数:2
相关论文
共 50 条
  • [1] ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma
    Okamura, Akihiko
    Watanabe, Masayuki
    Okui, Jun
    Matsuda, Satoru
    Takemura, Ryo
    Kawakubo, Hirofumi
    Takeuchi, Hiroya
    Muto, Manabu
    Kakeji, Yoshihiro
    Kitagawa, Yuko
    Doki, Yuichiro
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2186 - 2187
  • [2] ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma
    Akihiko Okamura
    Masayuki Watanabe
    Jun Okui
    Satoru Matsuda
    Ryo Takemura
    Hirofumi Kawakubo
    Hiroya Takeuchi
    Manabu Muto
    Yoshihiro Kakeji
    Yuko Kitagawa
    Yuichiro Doki
    Annals of Surgical Oncology, 2023, 30 : 2186 - 2187
  • [3] ASO Author Reflections: Prediction of the Therapeutic Efficacy in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
    Okamura, Akihiko
    Matsuda, Satoru
    Kawakubo, Hirofumi
    Mine, Shinji
    Takeuchi, Hiroya
    Kitagawa, Yuko
    Watanabe, Masayuki
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 795 - 796
  • [4] ASO Author Reflections: Prediction of the Therapeutic Efficacy in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
    Akihiko Okamura
    Satoru Matsuda
    Hirofumi Kawakubo
    Shinji Mine
    Hiroya Takeuchi
    Yuko Kitagawa
    Masayuki Watanabe
    Annals of Surgical Oncology, 2020, 27 : 795 - 796
  • [5] ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma
    Matsuda, Satoru
    Kawakubo, Hirofumi
    Okamura, Akihiko
    Takahashi, Keita
    Toihata, Tasuku
    Takemura, Ryo
    Mayanagi, Shuhei
    Takeuchi, Hiroya
    Watanabe, Masayuki
    Kitagawa, Yuko
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (13) : 8448 - 8449
  • [6] ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma
    Satoru Matsuda
    Hirofumi Kawakubo
    Akihiko Okamura
    Keita Takahashi
    Tasuku Toihata
    Ryo Takemura
    Shuhei Mayanagi
    Hiroya Takeuchi
    Masayuki Watanabe
    Yuko Kitagawa
    Annals of Surgical Oncology, 2021, 28 : 8448 - 8449
  • [7] ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment
    Sugiyama, Fumitake
    Kanda, Mitsuro
    Kodera, Yasuhiro
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (05) : 3473 - 3474
  • [8] ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment
    Fumitake Sugiyama
    Mitsuro Kanda
    Yasuhiro Kodera
    Annals of Surgical Oncology, 2024, 31 : 3473 - 3474
  • [9] ASO Author Reflections: The Challenging Journey from cCR to pCR After Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma
    Chen, Ke-Neng
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (7) : 4317 - 4320
  • [10] ASO Author Refections: Evaluation of Endoscopic Response After Neoadjuvant Chemotherapy Guides Distribution of Residual Diseases for Esophageal Squamous Cell Carcinoma
    Satoru Matsuda
    Hirofumi Kawakubo
    Takayuki Tsuji
    Junya Aoyama
    Yuki Hirata
    Ryo Takemura
    Shuhei Mayanagi
    Tomoyuki Irino
    Kazumasa Fukuda
    Rieko Nakamura
    Hiroya Takeuchi
    Yuko Kitagawa
    Annals of Surgical Oncology, 2022, 29 : 2681 - 2682